MEI Pharma to Consider Strategic Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Brookline Capital Markets Downgrades MEI Pharma (MEIP) to Hold
July 22, 2024 11:52 AM UTCBrookline Capital Markets analyst Leah Rush Cann downgraded MEI Pharma (NASDAQ: MEIP) from Buy to Hold.
The analyst comments "We cover MEI Pharma, a development-stage biotechnology company working in the PI3K pathway, CDK inhibition, epigenetics, and cancer metabolism, and... More
